Toll-like receptor 9-dependent activation of bone marrow-derived dendritic cells by URA5 DNA from Cryptococcus neoformans

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 778-786

  Tanaka, Misuzu ^a   Ishii, Keiko ^a   Nakamura, Yuri ^a   Miyazato, Akiko ^b   Maki, Atsuko ^a,c   Abe, Yuzuru ^a   Miyasaka, Tomomitsu ^a   Yamamoto, Hideki ^a   Akahori, Yukiko ^a   Fue, Misaki ^a   Takahashi, Yurie ^a   Kanno, Emi ^a   Maruyama, Ryoko ^a   Kawakami, Kazuyoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^c Yamagata Saisei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CD40 ANTIGEN; DNA FRAGMENT; ENDONUCLEASE; FUNGAL DNA; INTERLEUKIN 12P40; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CPG ISLAND; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DNA MODIFICATION; DNA SEQUENCE; FEMALE; FUNGAL GENE; INNATE IMMUNITY; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; URA5 GENE;

ANIMALS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; DNA, FUNGAL; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION REGULATION, FUNGAL; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGES; MICE; MICE, KNOCKOUT; OROTATE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATES; QUATERNARY AMMONIUM COMPOUNDS; TOLL-LIKE RECEPTOR 9;

EID: 84863135965     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05570-11     Document Type: Article

References (34)

1. Biondo C, et al. 2005. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur. J. Immunol. 35:870-878.
2. Casadevall A, Freundlich LF, Marsh L, Scharff MD. 1992. Extensive allelic variation in Cryptococcus neoformans. J. Clin. Microbiol. 30:1080-1084.
3. Edman JC, Kwon-Chung KJ. 1990. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10:4538-4544.
4. Feldmesser M, Tucker S, Casadevall A. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278.
5. Haas T, et al. 2008. The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 28:315-323.
6. Hemmi H, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
7. Hill JO, Harmsen AG. 1991. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med. 173:755-758.
8. Honda K, et al. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035-1040.
9. Kawai T, et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5:1061-1068.
10. Kawakami K, et al. 2001. Monocyte chemoattractant protein-1- dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167:6525-6532.
11. Koguchi Y, Kawakami K. 2002. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol. 21:423-438.
12. Krieg AM, et al. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
13. Krieg AM. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760.
14. Latz E, et al. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190-198.
15. Lim TS, Murphy JW. 1980. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun. 30:5-11.
16. Lipscomb MF, et al. 1987. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am. J. Pathol. 128:354-361.
17. Lutz MB, et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
18. Mansour MK, Latz E, Levitz SM. 2006. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176:3053-3061.
19. Mednick AJ, Feldmesser M, Rivera J, Casadevall A. 2003. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur. J. Immunol. 33:1744-1753.
20. Miyazato A, et al. 2009. Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect. Immun. 77:3056-3064.
21. Mody CH, Lipscomb MF, Street NE, Toews GB. 1990. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472-1477.
22. Nakamura K, et al. 2008. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J. Immunol. 180:4067-4074.
23. Petter R, Kang BS, Boekhout T, Davis BJ, Kwon-Chung KJ. 2001. A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59. Microbiology 147:2029-2036.
24. Ramirez-Ortiz ZG, et al. 2008. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect. Immun. 76:2123-2129.
25. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
26. Tanaka K, et al. 1996. Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. J. Clin. Microbiol. 34:2826-2828.
27. Uezu K, et al. 2004. Accumulation of γδ T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans. J. Immunol. 172:7629-7634.
28. Varma A, Edman JC, Kwon-Chung KJ. 1992. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect. Immun. 60:1101-1108.
29. Wagner H. 2008. The sweetness of the DNA backbone drives Toll-like receptor 9. Curr. Opin. Immunol. 20:396-400.
30. Xiao G, et al. 2010. Activation of myeloid dendritic cells by deoxynucleic acids from Cordyceps sinensis via a Toll-like receptor 9-dependent pathway. Cell. Immunol. 263:241-250.
31. Yasuda K, Rutz M, Schlatter B. 2006. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. Eur. J. Immunol. 36:431-436.
32. Yasuoka A, Kohno S, Yamada H, Kaku M, Koga H. 1994. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis. Microbiol. Immunol. 38:851-856.
33. Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. 2004. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72:5373-5382.
34. Zhang Y, et al. 2010. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am. J. Pathol. 177:754-765.